BNP Paribas Asset Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $16.9M | Sell |
|
|||||
|
2023
Q2 | $17M | Sell |
|
|||||
|
2023
Q1 | $24.1M | Buy |
|
|||||
|
2022
Q4 | $32.9M | Buy |
|
|||||
|
2022
Q3 | $28.7M | Buy |
|
|||||
|
2022
Q2 | $22.2M | Buy |
|
|||||
|
2022
Q1 | $27.1M | Sell |
|
|||||
|
2021
Q4 | $26.2M | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $199K | Buy |
|